Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: Matching for transplants from related haploidentical donors

Eric M. Mickelson, Leigh Ann Guthrie, Ruth Etzioni, Claudio Anasetti, Paul J. Martin, John A. Hansen

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Abstract: The utility of the MLC assay as a test of HLA‐D region matching and predictor of acute graft‐versus‐host disease (GvHD) was evaluated in 157 patients receiving marrow grafts from HLA‐A, B identical related haploidentical donors. All donors and recipients were tested by HLA‐DR serology, by Dw phenotyping with homozygous typing cells (HTC) and by standard MLC. Ninety‐nine of the donor‐recipient pairs were mismatched for a serologically defined HLA‐DR antigen while 109 pairs were mismatched for the HLA‐D region by HTC typing. Donor anti‐recipient relative responses (RR) in MLC, corresponding to the GvHD vector in marrow transplantation, ranged from ‐4% to 100%, with a median of 25%. A comparison of reactivity in MLC with presence or absence of matching by Dw phenotyping, however, showed a significant overlap in the distribution of RRs from HLA‐Dw matched versus Dw mismatched pairs, suggesting that the MLC was not a reliable predictor of HLA‐Dw matching. Using an optimally‐defined cutoff of 3% RR, the MLC was correlated with risk of developing clinically significant grades II–IV acute GvHD (p = 0.03) but not with risk of developing severe grades III‐IV GvHD (p = 0.18). In contrast, matching by Dw phenotype was a significant predictor of GvHD, with Dw‐compatible transplant recipients less likely to develop either grades II‐IV (p = 0.004) or III‐IV (p = 0.036) GvHD than Dw‐incompatible transplant recipients. Overall, these results underscore the difficulty in using the MLC to measure HLA‐D region compatibility and predict the risk of severe graft‐versus‐host disease among patients receiving related haploidentical marrow grafts. HLA‐D (HTC) typing results correlate primarily with DRB compatibility, and with the advent of DRB1 allele matching by sequence‐specific oligonucleotide probes (SSOP) or by direct sequencing, the precision in donor matching achievable with these methods is far greater than with either HLA‐D typing or direct MLC testing.

Original languageEnglish (US)
Pages (from-to)83-92
Number of pages10
JournalTissue Antigens
Volume44
Issue number2
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Donor Selection
Transplants
Mixed Lymphocyte Culture Test
Lymphocytes
Cell culture
Bone Marrow
Tissue Donors
Acute Disease
Grafts
Dichlororibofuranosylbenzimidazole
Disease Vectors
Oligonucleotide Probes
Serology
Assays
Transplantation
Alleles
Phenotype
Antigens
Testing

Keywords

  • donor selection
  • HLA haploidentical siblings
  • HLA‐D homozygous typing cells (HTC)
  • HLA‐D typing
  • marrow transplantation
  • mixed lymphocyte culture

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Biochemistry
  • Genetics

Cite this

Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection : Matching for transplants from related haploidentical donors. / Mickelson, Eric M.; Guthrie, Leigh Ann; Etzioni, Ruth; Anasetti, Claudio; Martin, Paul J.; Hansen, John A.

In: Tissue Antigens, Vol. 44, No. 2, 01.01.1994, p. 83-92.

Research output: Contribution to journalArticle

Mickelson, Eric M. ; Guthrie, Leigh Ann ; Etzioni, Ruth ; Anasetti, Claudio ; Martin, Paul J. ; Hansen, John A. / Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection : Matching for transplants from related haploidentical donors. In: Tissue Antigens. 1994 ; Vol. 44, No. 2. pp. 83-92.
@article{8d3066be2ea34c488aed9f1afdcba840,
title = "Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: Matching for transplants from related haploidentical donors",
abstract = "Abstract: The utility of the MLC assay as a test of HLA‐D region matching and predictor of acute graft‐versus‐host disease (GvHD) was evaluated in 157 patients receiving marrow grafts from HLA‐A, B identical related haploidentical donors. All donors and recipients were tested by HLA‐DR serology, by Dw phenotyping with homozygous typing cells (HTC) and by standard MLC. Ninety‐nine of the donor‐recipient pairs were mismatched for a serologically defined HLA‐DR antigen while 109 pairs were mismatched for the HLA‐D region by HTC typing. Donor anti‐recipient relative responses (RR) in MLC, corresponding to the GvHD vector in marrow transplantation, ranged from ‐4{\%} to 100{\%}, with a median of 25{\%}. A comparison of reactivity in MLC with presence or absence of matching by Dw phenotyping, however, showed a significant overlap in the distribution of RRs from HLA‐Dw matched versus Dw mismatched pairs, suggesting that the MLC was not a reliable predictor of HLA‐Dw matching. Using an optimally‐defined cutoff of 3{\%} RR, the MLC was correlated with risk of developing clinically significant grades II–IV acute GvHD (p = 0.03) but not with risk of developing severe grades III‐IV GvHD (p = 0.18). In contrast, matching by Dw phenotype was a significant predictor of GvHD, with Dw‐compatible transplant recipients less likely to develop either grades II‐IV (p = 0.004) or III‐IV (p = 0.036) GvHD than Dw‐incompatible transplant recipients. Overall, these results underscore the difficulty in using the MLC to measure HLA‐D region compatibility and predict the risk of severe graft‐versus‐host disease among patients receiving related haploidentical marrow grafts. HLA‐D (HTC) typing results correlate primarily with DRB compatibility, and with the advent of DRB1 allele matching by sequence‐specific oligonucleotide probes (SSOP) or by direct sequencing, the precision in donor matching achievable with these methods is far greater than with either HLA‐D typing or direct MLC testing.",
keywords = "donor selection, HLA haploidentical siblings, HLA‐D homozygous typing cells (HTC), HLA‐D typing, marrow transplantation, mixed lymphocyte culture",
author = "Mickelson, {Eric M.} and Guthrie, {Leigh Ann} and Ruth Etzioni and Claudio Anasetti and Martin, {Paul J.} and Hansen, {John A.}",
year = "1994",
month = "1",
day = "1",
doi = "10.1111/j.1399-0039.1994.tb02363.x",
language = "English (US)",
volume = "44",
pages = "83--92",
journal = "HLA",
issn = "2059-2302",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection

T2 - Matching for transplants from related haploidentical donors

AU - Mickelson, Eric M.

AU - Guthrie, Leigh Ann

AU - Etzioni, Ruth

AU - Anasetti, Claudio

AU - Martin, Paul J.

AU - Hansen, John A.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Abstract: The utility of the MLC assay as a test of HLA‐D region matching and predictor of acute graft‐versus‐host disease (GvHD) was evaluated in 157 patients receiving marrow grafts from HLA‐A, B identical related haploidentical donors. All donors and recipients were tested by HLA‐DR serology, by Dw phenotyping with homozygous typing cells (HTC) and by standard MLC. Ninety‐nine of the donor‐recipient pairs were mismatched for a serologically defined HLA‐DR antigen while 109 pairs were mismatched for the HLA‐D region by HTC typing. Donor anti‐recipient relative responses (RR) in MLC, corresponding to the GvHD vector in marrow transplantation, ranged from ‐4% to 100%, with a median of 25%. A comparison of reactivity in MLC with presence or absence of matching by Dw phenotyping, however, showed a significant overlap in the distribution of RRs from HLA‐Dw matched versus Dw mismatched pairs, suggesting that the MLC was not a reliable predictor of HLA‐Dw matching. Using an optimally‐defined cutoff of 3% RR, the MLC was correlated with risk of developing clinically significant grades II–IV acute GvHD (p = 0.03) but not with risk of developing severe grades III‐IV GvHD (p = 0.18). In contrast, matching by Dw phenotype was a significant predictor of GvHD, with Dw‐compatible transplant recipients less likely to develop either grades II‐IV (p = 0.004) or III‐IV (p = 0.036) GvHD than Dw‐incompatible transplant recipients. Overall, these results underscore the difficulty in using the MLC to measure HLA‐D region compatibility and predict the risk of severe graft‐versus‐host disease among patients receiving related haploidentical marrow grafts. HLA‐D (HTC) typing results correlate primarily with DRB compatibility, and with the advent of DRB1 allele matching by sequence‐specific oligonucleotide probes (SSOP) or by direct sequencing, the precision in donor matching achievable with these methods is far greater than with either HLA‐D typing or direct MLC testing.

AB - Abstract: The utility of the MLC assay as a test of HLA‐D region matching and predictor of acute graft‐versus‐host disease (GvHD) was evaluated in 157 patients receiving marrow grafts from HLA‐A, B identical related haploidentical donors. All donors and recipients were tested by HLA‐DR serology, by Dw phenotyping with homozygous typing cells (HTC) and by standard MLC. Ninety‐nine of the donor‐recipient pairs were mismatched for a serologically defined HLA‐DR antigen while 109 pairs were mismatched for the HLA‐D region by HTC typing. Donor anti‐recipient relative responses (RR) in MLC, corresponding to the GvHD vector in marrow transplantation, ranged from ‐4% to 100%, with a median of 25%. A comparison of reactivity in MLC with presence or absence of matching by Dw phenotyping, however, showed a significant overlap in the distribution of RRs from HLA‐Dw matched versus Dw mismatched pairs, suggesting that the MLC was not a reliable predictor of HLA‐Dw matching. Using an optimally‐defined cutoff of 3% RR, the MLC was correlated with risk of developing clinically significant grades II–IV acute GvHD (p = 0.03) but not with risk of developing severe grades III‐IV GvHD (p = 0.18). In contrast, matching by Dw phenotype was a significant predictor of GvHD, with Dw‐compatible transplant recipients less likely to develop either grades II‐IV (p = 0.004) or III‐IV (p = 0.036) GvHD than Dw‐incompatible transplant recipients. Overall, these results underscore the difficulty in using the MLC to measure HLA‐D region compatibility and predict the risk of severe graft‐versus‐host disease among patients receiving related haploidentical marrow grafts. HLA‐D (HTC) typing results correlate primarily with DRB compatibility, and with the advent of DRB1 allele matching by sequence‐specific oligonucleotide probes (SSOP) or by direct sequencing, the precision in donor matching achievable with these methods is far greater than with either HLA‐D typing or direct MLC testing.

KW - donor selection

KW - HLA haploidentical siblings

KW - HLA‐D homozygous typing cells (HTC)

KW - HLA‐D typing

KW - marrow transplantation

KW - mixed lymphocyte culture

UR - http://www.scopus.com/inward/record.url?scp=0028108099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028108099&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0039.1994.tb02363.x

DO - 10.1111/j.1399-0039.1994.tb02363.x

M3 - Article

C2 - 7817382

AN - SCOPUS:0028108099

VL - 44

SP - 83

EP - 92

JO - HLA

JF - HLA

SN - 2059-2302

IS - 2

ER -